Abacavir Base (CAS number 188062-50-2) is a significant antiviral mainly utilized in the treatment of HIV infection and connected secondary infections . It functions as a nucleoside inhibitor , interfering with the viral replication mechanism . Administered often in alongside other AIDS drugs , abacavir plays a key part in controlling the viral load and improving individual health . Careful genetic testing for the B*57:01 allele is necessary prior to start of this therapy to prevent the possibility of a serious reaction .
Abarelix (183552-38-7): Properties and Uses
Abarelix, identified by the ALANTOLACTONE 546-43-0 Chemical ID 183552-38-7, is a laboratory-created peptide antagonist of gonadotropin-releasing hormone (GnRH). This primary property lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a profound reduction in reproductive output . Therapeutically, abarelix is employed primarily in the treatment of advanced prostate malignancy ; however, research also explores possible roles in other hormonal imbalances and reproductive issues. The compound 's makeup allows for specific receptor interaction .
```text
Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data
The synthetic of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves detailed multistep laboratory routes. Several reported methods exist, often beginning with Androstadienedione and utilizing specific oxidation and reaction steps. A typical method includes protecting group strategies to ensure intended regioselectivity. Analytical data, crucial for quality control, routinely employs high-performance chromatography (HPLC) for quantification of purity. Nuclear Magnetic Resonance (NMR) analysis confirms the chemical identity. Mass spectrometry delivers molecular weight verification. Other analyses, like infrared (IR) spectroscopy, assist in assessment and are critical for lot release.
- Production Routes
- Purity Control
- Spectroscopic Characterization
```
```text
Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate
Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Knowing these identifiers aids in correct referencing and prevents confusion within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone a CYP17 inhibitor used in metastatic prostate cancer, possesses the CAS number 857342-50-7. Properly utilizing these numbers ensures clarity and consistency when discussing these medications.
- Compound A CAS Number: 60242-78-0
- Abarelix CAS Number: 5490-02-9
- Compound C CAS Number: 857342-50-7
```
Important Details on Abacavir , Abarelix Injection , and Abiraterone
These therapies represent distinct solutions in medicine. Abacavir is a antiviral primarily given to treat HIV disease , often in combination other antiviral . Abarelix for Treatment is a hormone that functions as a GnRH antagonist , typically employed to lower prostate tumors before operation . Lastly, Abiraterone is another medication administered to treat advanced prostate malignancies , specifically suppressing testosterone synthesis . Please consult a healthcare professional for specific information and guidance regarding any drug.
Pharmaceutical Perspectives: Abacavir Salt, Abarelix, Abiraterone Acetate and Their Chemical Abstracts Service Codes
Examining various pharmaceutical agents demands a defined determination. Particularly, Abacavir Sulfate, applied in AIDS therapy, has a CAS Number of 3870-92-6. Likewise, Abarelix, a hormone antagonist administered for prostate cancer care, bears the CAS Identifier 64347-82-2. To conclude, Abiraterone Acetate, a compound in aggressive prostate lesions, is known as associated with the Registration Code 864930-63-3. Such identifiers represent vital instruments to correct drug identification as well as research.